4//SEC Filing
SHERWOOD CHARLES H 4
Accession 0001171843-17-006236
CIK 0000898437other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:05 PM ET
Size
7.2 KB
Accession
0001171843-17-006236
Insider Transaction Report
Form 4
SHERWOOD CHARLES H
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2017-10-20$60.04/sh−5,991$359,700→ 158,297 total - Sale
Common Stock
2017-10-23$60.06/sh−22,228$1,335,014→ 136,069 total
Footnotes (2)
- [F1]On October 20, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 5,991 shares in multiple trades ranging from $60.00 to $60.13. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- [F2]On October 23, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 22,228 shares in multiple trades ranging from $60.00 to $60.22. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001244298
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 4:05 PM ET
- Size
- 7.2 KB